Literature DB >> 9723832

Severe coagulopathy after a bite of a green bush viper (Atheris squamiger): case report and biochemical analysis of the venom.

D Mebs1, K Holada, F Kornalík, J Simák, H Vanková, D Müller, H Schoenemann, H Lange, H W Herrmann.   

Abstract

A 34 year old male bitten by an adult Atheris squamiger snake developed symptoms of nausea, vomiting, diarrhea which were followed by drowsiness and impaired breathing. Local hemorrhage, edema and pain at the bite-site occurred, but no systemic bleeding or hemorrhagic diathesis developed. All clinical and laboratory parameters were in the normal range except for afibrinogenemia, thrombocytopenia and slight proteinuria. Replacement therapy (fibrinogen and platelet concentrates) and treatment of shock stabilized the patient within 2d and coagulation returned to normal. Atheris squamiger venom was subjected to biochemical and biological analysis. The LD50 of the venom was 5 mg/kg (mice, s.c.). It produced local hemorrhage corresponding to about 25% of the activity of puff adder venom (Bitis arietans). In vitro the venom had a fibrinogen-converting activity, it did not activate purified prothrombin but very likely contained a F V and Ca2+-dependent prothrombin activator. The venom exhibited strong platelet-aggregating activity, which was not inhibited by protease inhibitors and by EDTA or EGTA. The venom also aggregated acetylsalicylic acid treated platelets indicating, that the arachidonic acid pathway was not essential for activation. Rat serum rapidly inhibited the platelet-aggregating activity of the venom; human serum, however, had only a partial inhibitory effect. Preliminary experiments showed that platelet-aggregating activity may be separated from fibrinogen-converting activity by anion-exchange chromatography.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723832     DOI: 10.1016/s0041-0101(98)00008-7

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  Comparative Profiling of Three Atheris Snake Venoms: A. squamigera, A. nitschei and A. chlorechis.

Authors:  He Wang; Xiaole Chen; Enrico König; Mei Zhou; Lei Wang; Tianbao Chen; Chris Shaw
Journal:  Protein J       Date:  2018-08       Impact factor: 2.371

2.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

Review 3.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

4.  Fibrinogenolysis in Venom-Induced Consumption Coagulopathy after Viperidae Snakebites: A Pilot Study.

Authors:  Jiri Valenta; Alzbeta Hlavackova; Zdenek Stach; Jana Stikarova; Marek Havlicek; Pavel Michalek
Journal:  Toxins (Basel)       Date:  2022-08-06       Impact factor: 5.075

5.  African Bush Viper Envenomation: A Case Report.

Authors:  Nicholas S Imperato; Alexandra M Amaducci; Benjamin N Abo; Andrew L Koons; Derek J Fikse; Kenneth D Katz
Journal:  Cureus       Date:  2022-08-15

6.  Molecular Characterization of Three Novel Phospholipase A₂ Proteins from the Venom of Atheris chlorechis, Atheris nitschei and Atheris squamigera.

Authors:  He Wang; Xiaole Chen; Mei Zhou; Lei Wang; Tianbao Chen; Chris Shaw
Journal:  Toxins (Basel)       Date:  2016-06-01       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.